|
AMGN's Free Cash Flow Growth by Quarter and Year
Amgen Inc 's Free Cash Flow results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Free Cash Flow Growth Y/Y▼
|
Free Cash Flow Growth Y/Y▼
|
| AMGN Free Cash Flow (in millions $) |
FY 2023 |
FY 2022 |
FY 2021 |
FY 2020 |
| IV Quarter |
December |
-
|
2,649.00
|
2,808.00
|
2,153.00
|
| III Quarter |
September |
-
|
2,978.00
|
2,418.00
|
3,368.00
|
| II Quarter |
June |
4,109.00
|
1,930.00
|
1,931.00
|
2,842.00
|
| I Quarter |
March |
1,064.00
|
2,164.00
|
2,104.00
|
2,134.00
|
| FY |
|
5,173.00
|
9,721.00
|
9,261.00
|
10,497.00
|
| AMGN Free Cash Flow second quarter 2023 Y/Y Growth Comment |
Amgen Inc achieved in the second quarter 2023, above Company average Free Cash Flow surge of 112.9% year on year, to $ 4,109.00 millions.
Looking into second quarter 2023 results within Biotechnology & Pharmaceuticals industry 4 other companies have achieved higher Free Cash Flow growth. While Amgen Inc ' s Free Cash Flow doubling of 112.9% ranks overall at the positon no. 1102 in the second quarter 2023.
|
| AMGN Free Cash Flow ( Y/Y Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
-5.66 % |
30.42 % |
-14.36 % |
| III Quarter |
September |
- |
23.16 % |
-28.21 % |
-0.27 % |
| II Quarter |
June |
112.9 % |
-0.05 % |
-32.05 % |
100.99 % |
| I Quarter |
March |
-50.83 % |
2.85 % |
-1.41 % |
15.66 % |
| FY |
|
- |
4.97 % |
-11.77 % |
14.72 % |
AMGN Free Cash Flow (Quarter on Quarter Growth %) |
2023
|
2022 |
2021 |
2020 |
| IV Quarter |
December |
- |
-11.05 % |
16.13 % |
-36.07 % |
| III Quarter |
September |
- |
54.3 % |
25.22 % |
18.51 % |
| II Quarter |
June |
286.18 % |
-10.81 % |
-8.22 % |
33.18 % |
| I Quarter |
March |
-59.83 % |
-22.93 % |
-2.28 % |
-15.12 % |
| FY (Year on Year) |
|
- |
4.97 % |
-11.77 % |
14.72 % |
| Free Cash Flow Y/Y Growth Statistics |
| High |
Average |
Low |
| 145.53 % |
11.34 % |
-18.83 % |
| (Dec. 31. 2005) |
|
(Dec 31 2019) |
|
|
| Free Cash Flow Y/Y Growth Statistics |
| High |
Average |
Low |
| 145.53 % |
11.34 % |
-18.83 % |
| (Dec. 31. 2005) |
|
(Dec 31 2019) |
|
| Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023 |
Amgen Inc 's Q/Q Free Cash Flow Growth
| Free Cash Flow Q/Q Growth Statistics |
| High |
Average |
Low |
| 5931.25 % |
96.82 % |
-100 % |
| (June 30. 2004) |
|
|
| AMGN's II. Quarter Q/Q Free Cash Flow Comment |
Amgen Inc achieved in the II. Quarter 2023 above company average sequential Free Cash Flow doubling of 286.18%, to $ 4,109.00 millions, from $1,064.00 millions in the first quarter.
AMGN is going from strength to strength, with recording higher then regular increase, but also accelerating pace, Esme Williams, a business expert said.
Within Biotechnology & Pharmaceuticals industry Amgen Inc achieved highest sequential Free Cash Flow growth. While Amgen Inc 's Free Cash Flow growth quarter on quarter, overall rank is 186. |
|
|
|
| Free Cash Flow Q/Q Growth Statistics |
| High |
Average |
Low |
| 5931.25 % |
96.82 % |
-100 % |
| (June 30. 2004) |
|
|
| AMGN's II. Quarter Q/Q Free Cash Flow Comment |
Amgen Inc achieved in the II. Quarter 2023 above company average sequential Free Cash Flow doubling of 286.18%, to $ 4,109.00 millions, from $1,064.00 millions in the first quarter.
Biotechnology & Pharmaceuticals company is going from strength to strength, not only reporting better then average gain, and also increasing speed.
Within Biotechnology & Pharmaceuticals industry Amgen Inc achieved highest sequential Free Cash Flow growth. While Amgen Inc 's Free Cash Flow growth quarter on quarter, overall rank is 186. |
|
Amgen Inc 's 12 Months Free Cash Flow Growth Year on Year
Free Cash Flow TTM Growth |
12 Months Ending
(Jun 30 2023) |
12 Months Ending
(Mar 31 2023) |
12 Months Ending
(Dec 31 2022) |
12 Months Ending
(Sep 30 2022) |
12 Months Ending
(Jun 30 2022) |
| Cumulative Free Cash Flow 12 Months Ending |
$ 11,915.00 |
$ 9,711.00 |
$ 10,657.00 |
$ 10,763.00 |
$ 10,285.00 |
| Y / Y Free Cash Flow Growth (TTM) |
15.85 % |
-5.03 % |
5.09 % |
14.84 % |
0.69 % |
| Year on Year Free Cash Flow Growth Overall
Ranking |
# 1100 |
# 810 |
# 1385 |
# 618 |
# 837 |
| Seqeuential Free Cash Flow Change (TTM) |
22.7 % |
-8.88 % |
-0.98 % |
4.65 % |
0.59 % |
| Seq. Free Cash Flow Growth (TTM) Overall
Ranking |
# 1052 |
# 1494 |
# 1225 |
# 954 |
# 1342 |
| Cumulative Free Cash Flow growth
Comment |
Amgen Inc saw improvement in Free Cash Flow growth trend, posting cumulative 12 months Free Cash Flow growth of 15.85% year on year, to $ 11,915 millions if the fiscal year would have ended in Jun 30 2023.
Amgen Inc 's trailing twelve months Free Cash Flow growth was higher than company's average 11.34% and higher than -5.03% growth in Mar 31 2023.
The momentum was much higher from twelve months ended Mar 31 2023 clinched at 22.7 % rise from $9711 millions in twelve months ending a quarter before.
In the Healthcare sector 75 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 810 to 1100. |
| Free Cash Flow TTM Q/Q Growth Statistics |
| High |
Average |
Low |
145.53 % |
11.34 % |
-18.83 % |
| (Dec. 31. 2005) |
|
|
|
|
| Free Cash Flow TTM Y/Y Growth Statistics |
| High |
Average |
Low |
145.53 % |
11.34 % |
-18.83 % |
|
|
|
| Free Cash Flow TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 5 |
| Sector |
# 92 |
| S&P 500 |
# 1359 |
|
| Cumulative Free Cash Flow growth
Comment |
Amgen Inc saw improvement in Free Cash Flow growth trend, posting cumulative 12 months Free Cash Flow growth of 15.85% year on year, to $ 11,915 millions if the fiscal year would have ended in Jun 30 2023.
Amgen Inc 's trailing twelve months Free Cash Flow growth was higher than company's average 11.34% and higher than -5.03% growth in Mar 31 2023.
The momentum was much more impressive sequentially clinched at 22.7 % jump from $9711 millions in twelve months ending a quarter Mar 31 2023.
In the Healthcare sector 75 other companies have achieved higher trailing twelve month Free Cash Flow growth. While Free Cash Flow growth total ranking has deteriorated compare to previous quarter from 810 to 1100. |
| Free Cash Flow TTM Q/Q Growth Statistics |
| High |
Average |
Low |
145.53 % |
11.34 % |
-18.83 % |
| (Dec. 31. 2005) |
|
|
| Free Cash Flow TTM Y/Y Growth Statistics |
| High |
Average |
Low |
145.53 % |
11.34 % |
-18.83 % |
|
|
|
| Free Cash Flow TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 5 |
| Sector |
# 92 |
| S&P 500 |
# 1359 |
|
184.62%